A turning point has been reached in the land of ETFs, paving the way for smoother terrain ahead. In the past, the fledgling industry has experienced a slightly rocky road, with providers pitting the merits of their preferred replication method against each other.
Debate ensued, with proponents of traditional replication advocating their method as simple to understand and lacking in counterparty risk, while other product providers touted synthetic replication as superior in offering lower tracking error. But the days of solely promoting one replication method are over. Spurred by the attraction of offering access to the emerging markets, providers once seen as the bastions of physical replication have “evolved” to offer synthetic exposure to the likes of China, India and Russia. Obviously, there is still competition and providers aren’t s...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes